Evidence map›Paper›PMID 36900096›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Novel Host Response-Based Diagnostics to Differentiate the Etiology of Fever in Patients Presenting to the Emergency Department.

Johnny Atallah, Musie Ghebremichael, Kyle D Timmer, Hailey M Warren, Ella Mallinger, Ellen Wallace, Fiona R Strouts, David H Persing, Michael K Mansour

Full text read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Johnny AtallahDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-0681-9087
Musie GhebremichaelDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Kyle D TimmerDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-4295-0007
Hailey M WarrenDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Ella MallingerDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Ellen WallaceDH Diagnostics LLC, Brea, CA 92821, USA.
Fiona R StroutsDH Diagnostics LLC, Brea, CA 92821, USA.
David H PersingDH Diagnostics LLC, Brea, CA 92821, USA.
Michael K MansourDepartment of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Funding

The role of spleen tyrosine kinase (syk) in neutrophil responses to pathogenic fungi.R01AI132638 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MANSOUR, MICHAEL K · 2018 to 2021
$1.6M
NIAID NIH HHS R01 AI132638NIH HHS RO1 AI132638
6 · The paper itself

Abstract

Fever is a common presentation to urgent-care services and is linked to multiple disease processes. To rapidly determine the etiology of fever, improved diagnostic modalities are necessary. This prospective study of 100 hospitalized febrile patients included both positive (FP) and negative (FN) subjects in terms of infection status and 22 healthy controls (HC). We evaluated the performance of a novel PCR-based assay measuring five host mRNA transcripts directly from whole blood to differentiate infectious versus non-infectious febrile syndromes as compared to traditional pathogen-based microbiology results. The FP and FN groups observed a robust network structure with a significant correlation between the five genes. There were statistically significant associations between positive infection status and four of the five genes: IRF-9 (OR = 1.750, 95% CI = 1.16-2.638), ITGAM (OR = 1.533, 95% CI = 1.047-2.244), PSTPIP2 (OR = 2.191, 95% CI = 1.293-3.711), and RUNX1 (OR = 1.974, 95% CI = 1.069-3.646). We developed a classifier model to classify study participants based on these five genes and other variables of interest to assess the discriminatory power of the genes. The classifier model correctly classified more than 80% of the participants into their respective groups, i.e., FP or FN. The GeneXpert prototype holds promise for guiding rapid clinical decision-making, reducing healthcare costs, and improving outcomes in undifferentiated febrile patients presenting for urgent evaluation.

Indexed as

diagnosticsfebrile syndromesfevergene signatureshost-response

Identifiers

PMID36900096
PMCPMC10000761

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read70
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.